المؤلفون: Heng-Zhen Li, Jing-lve Zhang, Dong-Liang Yuan, Wen-Qing Xie, Christoph H. Ladel, Ali Mobasheri, Yu-Sheng Li

المصدر: Military Medical Research, Vol 11, Iss 1, Pp 1-23 (2024)

مصطلحات موضوعية: Fibroblast growth factor (FGF), Fibroblast growth factor receptor (FGFR), Osteoarthritis (OA), Intervertebral disc degeneration (IVDD), Orthopedic degeneration, Osteoporosis (OP), Medicine (General), R5-920, Military Science

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2054-9369

URL الوصول: https://doaj.org/article/4ceb09a5a6724476871ca3feebd558f8

المؤلفون: Sheldon L. Holder, Ming Yin, Monika Joshi

المصدر: Frontiers in Oncology, Vol 14 (2024)

مصطلحات موضوعية: urothelial cell carcinoma (UCC), nectin 4, enfortumab vedotin, fibroblast growth factor receptor (FGFR), erdafitinib, HER2, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2024.1430285/full; https://doaj.org/toc/2234-943X

URL الوصول: https://doaj.org/article/a4084586bc1f442cb1a630e30a4b1a5b

المؤلفون: Kaylie A. Flores, Jorge L. Pérez-Moreno, David S. Durica, Donald L. Mykles

المصدر: Frontiers in Endocrinology, Vol 15 (2024)

مصطلحات موضوعية: receptor tyrosine kinase (RTK), epidermal growth factor receptor (EGFR), insulin receptor (INSR), fibroblast growth factor receptor (FGFR), vascular endothelial growth factor receptor (VEGF), platelet-derived growth factor receptor (PDGFR), Diseases of the endocrine glands. Clinical endocrinology, RC648-665

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fendo.2024.1379231/full; https://doaj.org/toc/1664-2392

URL الوصول: https://doaj.org/article/4ed12252abb54525812c57f25a6c0fda

المؤلفون: Li, Heng-Zhen^{Aff1, Aff2}, Zhang, Jing-lve^{Aff3, Aff4}, Yuan, Dong-Liang^{Aff1, Aff4}, Xie, Wen-Qing^{Aff1, Aff2}, Ladel, Christoph H.^{Aff5, IDs40779024005445_cor5}, Mobasheri, Ali^{Aff6, Aff7, Aff8, Aff9, Aff10, IDs40779024005445_cor6}, Li, Yu-Sheng^{Aff1, Aff2, IDs40779024005445_cor7}

المصدر: Military Medical Research. 11(1)

المؤلفون: Zhang, Xinzhi, Wen, Xin, Hu, Geng, Zhang, Qiang, Sun, Qianying, Jia, Yanxin, Liu, Yan, Lin, Hai^{Aff2, IDs11033022076991_cor8}, Li, Haifang^{Aff1, IDs11033022076991_cor9}

المصدر: Molecular Biology Reports: An International Journal on Molecular and Cellular Biology. 49(9):8641-8649

المؤلفون: Viviana Cortiana, Harshal Chorya, Muskan Joshi, Shreevikaa Kannan, Diksha Mahendru, Harshitha Vallabhaneni, Helena S. Coloma, Yan Leyfman, Chandler H. Park

المصدر: Cancers, Vol 16, Iss 3, p 632 (2024)

مصطلحات موضوعية: cholangiocarcinoma, biliary tract cancers, fibroblast growth factor receptor (FGFR), IDH (isocitrate dehydrogenase), insertions and deletions (INDELs), Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.mdpi.com/2072-6694/16/3/632; https://doaj.org/toc/2072-6694

URL الوصول: https://doaj.org/article/c8d5a78ee5d94779ab861b1b84dae534

المؤلفون: Keren Rouvinov, Eran Levanon, Avivit Peer, Michal Sarfaty, David Sarid, Victoria Neiman, Eduard Grikshtas, Eli Rosenbaum, Igal Kushnir, Barak Talmor, Michael Friger, Yonaton Zarbiv, Eli Gez, Hadas Dresler, Walid Shalata, Amichay Meirovitz, Noa Shani Shrem, Alexander Yakobson, Wilmosh Mermershtain, Daniel Keizman

المصدر: Frontiers in Oncology, Vol 13 (2023)

مصطلحات موضوعية: erdafitinib, metastatic urothelial carcinoma, treatment, real-world analysis, fibroblast growth factor receptor (FGFR) inhibitor, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2023.1151701/full; https://doaj.org/toc/2234-943X

URL الوصول: https://doaj.org/article/5d97724776e04b738ec6fc3ae439db56

المؤلفون: Yang Chen, Jingya Han, Yan Zhao, Xinming Zhao, Mengmeng Zhao, Jingmian Zhang, Jianfang Wang

المصدر: Frontiers in Oncology, Vol 13 (2023)

مصطلحات موضوعية: targeting peptide, fluorine-18, molecular imaging, fibroblast growth factor receptor (FGFR), malignant tumor, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2023.1047080/full; https://doaj.org/toc/2234-943X

URL الوصول: https://doaj.org/article/1f53d384951d46f296745574c58941a2

المؤلفون: Teng Li, Wuyun Hu, Lan Jin, Xianghua Yin, Dongxu Kang, Longzhen Piao

المصدر: Frontiers in Oncology, Vol 13 (2023)

مصطلحات موضوعية: urothelial cancer (UC), anlotinib, fibroblast growth factor receptor (FGFR), tislelizumab, PD-L1, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2023.1164368/full; https://doaj.org/toc/2234-943X

URL الوصول: https://doaj.org/article/e21302c6b7a443bb9b6a8b30bf2cb16b

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.